US Patent 7605239 Skeletal-targeted radiation to treat bone-associated pathologies
Patent 7605239 was granted and assigned to Poniard Pharmaceuticals, Inc. on October, 2009 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 7605239 Skeletal-targeted radiation to treat bone-associated pathologies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
